Tenet Healthcare (NYSE:THC – Get Free Report) announced its earnings results on Wednesday. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49, Zacks reports. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. Tenet Healthcare updated its FY 2025 guidance to 11.740-12.840 EPS.
Tenet Healthcare Stock Performance
Tenet Healthcare stock traded down $8.73 during mid-day trading on Wednesday, hitting $130.10. 1,647,157 shares of the company’s stock traded hands, compared to its average volume of 1,064,176. Tenet Healthcare has a one year low of $86.90 and a one year high of $171.20. The company has a market cap of $12.37 billion, a PE ratio of 4.17, a price-to-earnings-growth ratio of 0.63 and a beta of 2.05. The firm has a 50 day moving average price of $133.85 and a 200 day moving average price of $148.52. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35.
Wall Street Analysts Forecast Growth
THC has been the subject of a number of recent analyst reports. Wells Fargo & Company downgraded shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $205.00 to $150.00 in a research report on Monday, November 25th. Barclays boosted their target price on shares of Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a research report on Tuesday, December 17th. UBS Group upped their price objective on Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Finally, Royal Bank of Canada lifted their target price on Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Three equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $165.00.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Further Reading
- Five stocks we like better than Tenet Healthcare
- Trading Halts Explained
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Dividend Capture Strategy: What You Need to Know
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
- 3 Tickers Leading a Meme Stock Revival
- Shopify Confirms Stock Uptrend, New Highs in Sight
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.